FDA Issues Guidance on Off-Label Use Information

Mar 05, 2014

MedPageToday

The FDA has updated its guidance on ways in which drug and device manufacturers can distribute peer-reviewed information about off-label uses of medical products. The draft guidance offers a checklist for manufacturers to meet before scientific or medical journals can flow from sales representatives to physicians. The FDA said the information must: 

  • Be published by an organization which has an editorial board with independent expert
  • Be peer-reviewed
  • Be an unabridged reprint
  • Be distributed with approved labeling
  • Be distributed separately from promotional information
  • Include opposing views -- when available -- regarding the unapproved use

Read the full story

Join the discussion

We welcome your thoughtful comments. Please comply with our Community rules.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments